BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 18087177)

  • 1. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
    Kudo M; Okanoue T;
    Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
    Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
    Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].
    Ikai I
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):343-8. PubMed ID: 19068716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and treatment algorithm of the Japanese society of hepatology: a consensus-based practice guideline.
    Izumi N
    Oncology; 2010 Jul; 78 Suppl 1():78-86. PubMed ID: 20616588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress.
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():180-8. PubMed ID: 20616602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
    Yamakado K; Kudo M
    Oncology; 2014; 87 Suppl 1():78-81. PubMed ID: 25427737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Practice guidelines for management of hepatocellular carcinoma 2009].
    Korean Liver Cancer Study Group and National Cancer Center, Korea
    Korean J Hepatol; 2009 Sep; 15(3):391-423. PubMed ID: 19783891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma: current management and perspectives for the future.
    Rahbari NN; Mehrabi A; Mollberg NM; Müller SA; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):453-69. PubMed ID: 21263310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of hepatocellular carcinoma: an update].
    Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
    Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA; Welling T
    Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.
    Ichida T; Van Thiel DH; Hassanein T
    Hepatogastroenterology; 1996; 43(12):1575-83. PubMed ID: 8975968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R; Llovet JM
    Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan.
    Kudo M; Kitano M; Sakurai T; Nishida N
    Dig Dis; 2015 Oct; 33(6):765-70. PubMed ID: 26488173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma (primary cancer of the liver).
    Barbare JC; Boige V; Boudjema K; Lescesne R; Trinchet JC
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S57-2S61. PubMed ID: 17151564
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines.
    Kokudo N; Makuuchi M
    J Gastroenterol; 2009; 44 Suppl 19():119-21. PubMed ID: 19148805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prognosis of hepatocellular carcinoma: a population based study in France.
    Borie F; Bouvier AM; Herrero A; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
    J Surg Oncol; 2008 Dec; 98(7):505-9. PubMed ID: 18932235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
    Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y;
    Oncology; 2014; 87 Suppl 1():7-21. PubMed ID: 25427729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma: a multidisciplinary approach].
    Tempia-Caliera AA; Ksontini R; Moradpour D; Denys A; Halkic N
    Rev Med Suisse; 2005 Jun; 1(24):1621-4, 1627-9. PubMed ID: 16028708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.